Biblio

Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is O  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
Monroy EAlonso Cru, Santos PPaulo de A, Lopes MLuiza Dini, Mosqueda-Taylor A, Pinto LPereira, de Souza LBatista. Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions. Histochem Cell Biol. 2018.
Ng WL, Chen G, Wang M, Wang H, Story M, Shay JW, Zhang X, Wang J, Amin ARMR, Hu B, et al. OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation. Cell Death Dis. 2014;5:e1024.
Wu G, Wilson G, Zhou G, Hebbard L, George J, Qiao L. Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma. Discov Med. 2015;20(110):219-229.
Deveale B, Brokhman I, Mohseni P, Babak T, Yoon C, Lin A, Onishi K, Tomilin A, Pevny L, Zandstra PW, et al. Oct4 is required ∼e7.5 for proliferation in the primitive streak. PLoS Genet. 2013;9(11):e1003957.
Tsai L-L, Hu F-W, Lee S-S, Yu C-H, Yu C-C, Chang Y-C. Oct4 Mediates Tumor Initiating Properties in Oral Squamous Cell Carcinomas through the Regulation of Epithelial-Mesenchymal Transition. PLoS One. 2014;9(1):e87207.
Kim SJin, Koo OJae, Park HJung, Moon JHo, da Torre BRoibas, Javaregowda PKanive, Kang JTaek, Park SJi, Saadeldin IM, Choi JYei, et al. Oct4 overexpression facilitates proliferation of porcine fibroblasts and development of cloned embryos. Zygote. 2014:1-8.
Tao Y, Liu X, Cui L, Liu X, Chen Y, He Z, Ji M, Gao Z, Li N, Wan Z, et al. Oct4 plays a role in 2, 3, 7, 8 - tetrachlorobenzo-p-dioxin (TCDD) inducing cleft palate and inhibiting mesenchymal proliferation. Toxicology. 2020:152444.
Zeineddine D, Hammoud AAbou, Mortada M, Boeuf H. The Oct4 protein: more than a magic stemness marker. Am J Stem Cells. 2014;3(2):74-82.
Wen K-M, Zhang G-H, Li J, Chen Z-Q, Cheng Y-L, Su X, Zeng Q-L. OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to οxaliplatin in colon cancer. Oncol Rep. 2015.
Chen Y, Wu Z, Zhu X, Zhang M, Zang X, Li X, Xu Y. OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6. Exp Neurol. 2019.
Li R, Vannitamby A, Zhang J-G, Fehmel EL, Southwell BR, Hutson JM. Oct4-GFP expression during transformation of gonocytes into spermatogonial stem cells in the perinatal mouse testis. J Pediatr Surg. 2015.
Alabdi L, Saha D, He M, Dar MSaleem, Utturkar SM, Sudyanti PAyu, McCune S, Spears BH, Breedlove JA, Lanman NA, et al. Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers. Cell Rep. 2020;30(5):1478-1490.e6.
Chai S, Ng K-Y, Tong M, Lau EY, Lee TK, Chan KWah, Yuan Y-F, Cheung T-T, Cheung S-T, Wang X-Q, et al. Oct4/miR-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Hepatology. 2016.
Zimmerman DL, Boddy CS, Schoenherr CS. Oct4/Sox2 binding sites contribute to maintaining hypomethylation of the maternal igf2/h19 imprinting control region. PLoS One. 2013;8(12):e81962.
Zorin VL, Komlev VS, Zorina AI, Khromova NV, Solovieva EV, Fedotov AYu, Eremin II, Kopnin PB. Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts. Biomed Mater. 2014;9(5):055005.
Ko DSung, Lee DRyul, Song H, Kim J-H, Lim CKyu. Octylphenol and nonylphenol affect decidualization of human endometrial stromal cells. Reprod Toxicol. 2019.
Singh P, Tyagi M, Kumar Y, Gupta KK, Sharma PD. Ocular chemical injuries and their management. Oman J Ophthalmol. 2013;6(2):83-86.
Felder-Schmittbuhl M-P, Buhr ED, Dkhissi-Benyahya O, Hicks D, Peirson SN, Ribelayga CP, Sandu C, Spessert R, Tosini G. Ocular Clocks: Adapting Mechanisms for Eye Functions and Health. Invest Ophthalmol Vis Sci. 2018;59(12):4856-4870.
Nassiri N, Eslani M, Panahi N, Mehravaran S, Ziaei A, Djalilian AR. Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations. J Ophthalmic Vis Res. 2013;8(4):351-358.
Balasubramaniam SC, Raja H, Nau CB, Shen JF, Schornack MM. Ocular Graft-Versus-Host Disease: A Review. Eye Contact Lens. 2015.
Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, et al. Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biol Blood Marrow Transplant. 2018.
Fenzl CR, Teramoto K, Moshirfar M. Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses. Clin Ophthalmol. 2015;9:1633-1644.
Nassar A, Tabbara KF, Aljurf M. Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol. 2013;27(3):215-22.
Sulyok M, Rózsa L, Bodó I, Tappe D, Hardi R. Ocular Pentastomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2014;8(7):e3041.
Dhamodaran K, Subramani M, Ponnalagu M, Shetty R, Das D. Ocular stem cells: a status update!. Stem Cell Res Ther. 2014;5(2):56.

Pages